Omission of Surgical Axillary Staging Noninferior To Sentinel Lymph Node Biopsy in Patients with cN0, T1 or T2 Invasive Breast Cancer By Ogkologos - January 14, 2025 949 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the INSEMA study Source RELATED ARTICLESMORE FROM AUTHOR Comprehensive Genomic Profiling with Subsequent Molecularly Guided Therapy Improves Outcomes Over Platinum-based Chemotherapy in Previously Untreated, Unfavourable CUP NCI and CRUK Take on Cancer’s Toughest Problems Tebentafusp Continues to Provide Long-Term OS Benefit in Previously Untreated Patients with Unresectable or Metastatic Uveal Melanoma MOST POPULAR FDA Approves Durvalumab for Resectable Gastric or Gastro-Oesophageal Junction Adenocarcinoma December 5, 2025 EMA Recommends Granting a Marketing Authorisation for Generic Dasatinib February 10, 2022 Her Massive Weight Loss Helped Her Feel A Lump In Her... January 24, 2020 Research with integrity – why colour blindness is a research integrity... February 28, 2023 Load more HOT NEWS Breast Cancer Risk Genes 10 Things Diet Soda Does to Your Body If You Drink... Lorlatinib Slows Growth of ALK-Positive Lung Cancers, May Prevent Brain Metastases One year on: How has COVID-19 affected cancer services?
